In a milestone that’s equal parts innovation and “why weren’t we doing this already,” Intrinsic Therapeutics, Inc. has announced the first endoscopic implantation of the Barricaid® Bone-Anchored Annular Closure Device in the Great Lakes Region.
Spine Premium
Endoscopy Meets Annular Closure
1 min read Premium comments

PremiumAmplify SurgicalIntrinsic TherapeuticsBarricaid Bone-Anchored Annular Closure DevicedualPortal®Greg LambrechtNick Nenadovich#endoscopy
React:
